These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32638483)

  • 21. 3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis.
    Puchstein D; Kork F; Schöchl H; Rayatdoost F; Grottke O
    Thromb Haemost; 2023 Jan; 123(1):40-53. PubMed ID: 36626899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study.
    Yoshimura S; Sato S; Todo K; Okada Y; Furui E; Matsuki T; Yamagami H; Koga M; Takahashi JC; Nagatsuka K; Arihiro S; Toyoda K;
    J Neurol Sci; 2017 Apr; 375():150-157. PubMed ID: 28320118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding.
    Go AS; Leong TK; Sung SH; Wei R; Harrison TN; Gupta N; Baker N; Goldstein B; Ataher Q; Solomon MD; Reynolds K;
    J Thromb Thrombolysis; 2022 Oct; 54(3):470-479. PubMed ID: 35984591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis.
    Zeeshan M; Hamidi M; Feinstein AJ; Gries L; Jehan F; Sakran J; Northcutt A; OʼKeeffe T; Kulvatunyou N; Joseph B
    J Trauma Acute Care Surg; 2019 Aug; 87(2):274-281. PubMed ID: 30889141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
    Sin JH; Berger K; Lesch CA
    J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacist Presence Decreases Time to Prothrombin Complex Concentrate in Emergency Department Patients with Life-Threatening Bleeding and Urgent Procedures.
    Masic D; Hidalgo DC; Kuhrau S; Chaney W; Rech MA
    J Emerg Med; 2019 Nov; 57(5):620-628. PubMed ID: 31447188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.
    Smith MN; Deloney L; Carter C; Weant KA; Eriksson EA
    J Thromb Thrombolysis; 2019 Aug; 48(2):250-255. PubMed ID: 30941571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.
    Bouzat P; Charbit J; Abback PS; Huet-Garrigue D; Delhaye N; Leone M; Marcotte G; David JS; Levrat A; Asehnoune K; Pottecher J; Duranteau J; Courvalin E; Adolle A; Sourd D; Bosson JL; Riou B; Gauss T; Payen JF;
    JAMA; 2023 Apr; 329(16):1367-1375. PubMed ID: 36942533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.
    Barillari G; Pasca S; Barillari A; De Angelis V
    Blood Transfus; 2012 Jan; 10(1):87-94. PubMed ID: 22044952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
    Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
    Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages.
    Pham H; Medford WG; Horst S; Levesque M; Ragoonanan D; Price C; Colbassani H; Piper K; Chastain K
    Am J Emerg Med; 2022 May; 55():38-44. PubMed ID: 35272069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
    Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
    Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy.
    AlSheef M; Kullab G; Alajmi M; Aldhaheri R; Al Baqmi S; Alajlan H; Zaidi ARZ; Abu-Shaheen A
    Saudi Med J; 2022 Feb; 43(2):213-217. PubMed ID: 35110348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prothrombin complex concentrate vs. fresh frozen plasma in adult patients undergoing heart surgery - a pilot randomised controlled trial (PROPHESY trial).
    Green L; Roberts N; Cooper J; Agarwal S; Brunskill SJ; Chang I; Gill R; Johnston A; Klein AA; Platton S; Rossi A; Sepehripour A; Stanworth S; Monk V; O'Brien B
    Anaesthesia; 2021 Jul; 76(7):892-901. PubMed ID: 33285008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series.
    Liu J; Elsamadisi P; Philips E; Bauer KA; Eche IM
    Am J Health Syst Pharm; 2022 Aug; 79(16):1323-1329. PubMed ID: 35291008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.
    Yanamadala V; Walcott BP; Fecci PE; Rozman P; Kumar JI; Nahed BV; Swearingen B
    J Clin Neurosci; 2014 Nov; 21(11):1881-4. PubMed ID: 24953825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergent reversal of vitamin K antagonists: addressing all the factors.
    Martin DT; Barton CA; Dodgion C; Schreiber M
    Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.